These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 6208330)
1. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. MacKenzie RG; Zigmond MJ J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330 [TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. George SR; Watanabe M; Seeman P J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204 [TBL] [Abstract][Full Text] [Related]
3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
4. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro. Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587 [TBL] [Abstract][Full Text] [Related]
5. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations. Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872 [TBL] [Abstract][Full Text] [Related]
6. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation. Korf J; Sebens JB J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979 [TBL] [Abstract][Full Text] [Related]
7. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission. Savasta M; Dubois A; Benavidès J; Scatton B Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672 [TBL] [Abstract][Full Text] [Related]
8. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Wilmot CA; Szczepanik AM Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063 [TBL] [Abstract][Full Text] [Related]
9. Immuno-photoaffinity labeling of the D2-dopamine receptor. Kanety H; Fuchs S Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727 [TBL] [Abstract][Full Text] [Related]
10. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis. LaHoste GJ; Marshall JF Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501 [TBL] [Abstract][Full Text] [Related]
11. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms. Norman AB; Battaglia G; Creese I J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771 [TBL] [Abstract][Full Text] [Related]
12. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA; Marsh CL Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [TBL] [Abstract][Full Text] [Related]
13. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates. de Vries DJ; Beart PM Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232 [TBL] [Abstract][Full Text] [Related]
14. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections. Richfield EK; Young AB; Penney JB Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686 [TBL] [Abstract][Full Text] [Related]
16. Development of specificity and stereoselectivity of rat brain dopamine receptors. Miller JC; Friedhoff AJ Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672 [TBL] [Abstract][Full Text] [Related]
17. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat. Neve KA; Marshall JF Neurosci Lett; 1984 Apr; 46(1):77-83. PubMed ID: 6203067 [TBL] [Abstract][Full Text] [Related]
18. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609 [TBL] [Abstract][Full Text] [Related]
19. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. Levant B; Grigoriadis DE; DeSouza EB J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154 [TBL] [Abstract][Full Text] [Related]
20. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands. Urwyler S; Coward D Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]